Delphia Therapeutics
PrivateLast Round
Series A
May 2, 2024
Total Funding Raised
$67M
Company Overview
Delphia Therapeutics is a biotechnology company that develops innovative cancer therapeutics using an activation lethality platform to target cancer-linked cell signaling pathways.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Delphia Therapeutics Comparables
Compare Delphia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nested Therapeutics | 85% | |
| Alterome Therapeutics | 81% | |
| Tango Therapeutics | 80% | |
Delphia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 2, 2024 |
Delphia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series A, Seed |
| Alexandria Venture Investments | Series A |
| Nextech Invest | Series A |
| Polaris Partners | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2025
Steve Kelsey, M.D. appointed to the board of directors.
- May 28, 2025
Reza Mazhari appointed as the new chief business officer.
Delphia Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Delphia Therapeutics's valuation, stock price, and market status.